98 related articles for article (PubMed ID: 10050694)
1. Warfarin prophylaxis after total knee arthroplasty.
Lieberman JR
Am J Knee Surg; 1999; 12(1):49-53. PubMed ID: 10050694
[TBL] [Abstract][Full Text] [Related]
2. The role of low molecular weight heparin in total knee arthroplasty.
Iobst CA; Friedman RJ
Am J Knee Surg; 1999; 12(1):55-60. PubMed ID: 10050695
[TBL] [Abstract][Full Text] [Related]
3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
4. Warfarin vs enoxaparin for deep venous thrombosis prophylaxis after total hip & total knee arthroplasty: a cost comparison.
Garcia-Zozaya I
J Ky Med Assoc; 1998 Apr; 96(4):143-8. PubMed ID: 9577110
[TBL] [Abstract][Full Text] [Related]
5. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
Dager WE
Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
[TBL] [Abstract][Full Text] [Related]
6. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
7. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
8. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
Enyart JJ; Jones RJ
Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
[TBL] [Abstract][Full Text] [Related]
9. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Sarasin FP; Bounameaux H
Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
[TBL] [Abstract][Full Text] [Related]
10. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
11. The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty.
Pellegrini VD; Donaldson CT; Farber DC; Lehman EB; Evarts CM
Clin Orthop Relat Res; 2006 Nov; 452():21-7. PubMed ID: 16906107
[TBL] [Abstract][Full Text] [Related]
12. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism following total knee replacement.
Choi BY; Huo MH
J Surg Orthop Adv; 2007; 16(1):31-5. PubMed ID: 17371645
[TBL] [Abstract][Full Text] [Related]
14. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
Jaff MR
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S17-21. PubMed ID: 19213061
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
Keeney JA; Clohisy JC; Curry MC; Maloney WJ
J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: a survey of the AAHKS membership.
Mesko JW; Brand RA; Iorio R; Gradisar I; Heekin R; Leighton R; Thornberry R
J Arthroplasty; 2001 Sep; 16(6):679-88. PubMed ID: 11547365
[TBL] [Abstract][Full Text] [Related]
17. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era..
Mohapatra R; Tran M; Gore JM; Spencer FA
Am Heart J; 2005 Jul; 150(1):19-26. PubMed ID: 16084146
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic disease in total knee arthroplasty.
Jimenez MA; Trousdale RT
Instr Course Lect; 2001; 50():415-9. PubMed ID: 11372342
[TBL] [Abstract][Full Text] [Related]
19. Optimal initial dose adjustment of warfarin in orthopedic patients.
Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
[TBL] [Abstract][Full Text] [Related]
20. [Long-term prophylaxis after venous thromboembolism].
Gøtze JP; Friis-Hansen LJ; Thorsen S; Rehfeld JF
Ugeskr Laeger; 2003 Jul; 165(29):2896-7. PubMed ID: 12908362
[No Abstract] [Full Text] [Related]
[Next] [New Search]
